newsfilter
← Latest News
GlobeNewswire·

Olema Oncology Reports First Quarter 2026 Financial and Operating Results

Top-line data from the Phase 3 OPERA-01 trial anticipated this fall; Phase 3 OPERA-02 trial continues to enroll patientsFirst clinical data from OP-3136 Phase 1 study to be presented at ASCO Ended the first quarter with